Skip to main navigation
logo
  • COVID-19
  • Simoa® Technology
  • Therapeutic Areas
    • Neurology
    • Oncology
    • Immunology/Inflammation
    • Infectious Disease
    • Cardiology
  • Products & Services
    • Simoa® Assay Kits
    • HD-X Analyzer™
    • SR-X™ Biomarker Detection System
    • SP-X Imaging and Analysis System™
    • Simoa® Accelerator Laboratory
    • Uman NF-Light™
    • Homebrew – Custom Assay Development
  • Support & Resources
    • Customer Care & Technical Support
    • Safety Data Sheets & Cert. of Analysis
    • Product Brochures
    • Whitepapers & App Notes
    • Publications and Posters
    • Conferences
    • Webinars
  • Media Center
    • Press Releases
    • Videos and Recordings
    • In The News
    • Blog
  • Company
    • Contact Us
    • Meet the Management Team
  • Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • Press Releases
      • Investor Calendar
    • Investor Resources
      • Presentations
      • Investor FAQ
      • Information Request
      • Email Alerts
      • IR Contacts
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
      • Board Diversity Matrix
    • Annual Reports
  • Customer Portal

2018 Annual Meeting

2018 Annual Meeting

2018 Proxy Statement 125.7 KB
2017 Annual Report 1.1 MB
Print Page
Print Page
Email Alerts
Email Alerts
RSS
RSS
IR Contacts
IR Contacts
Quanterix Footer Logo
> Footer Links 1
  • info@quanterix.com
  • 617 301 9400
  • 900 middlesex tpke billerica, ma 01821 usa
> Footer Links 2
  • Investor Portal
  • Customer Portal
  • Contact Us

Connect with us on social media.

Facebook Icon (svg format) Twitter Icon (svg format) Linkedin Icon (svg format) Youtube Icon (svg format)

> Footer Bottom

  • Terms And Conditions
  • Privacy Shield Statement
  • Privacy Policy
  • © 2022 Quanterix All rights reserved.